← Back to Clinical Trials
Recruiting NCT04859270

NCT04859270 The Holistic Health Care of Post-Cardiac Arrest Survivors: From Patient's Health to Family Resilience

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04859270
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Post-Cardiac Arrest Syndrome
Study Type OBSERVATIONAL
Enrollment 600 participants
Start Date 2021-04-12
Primary Completion 2026-01-31

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 600 participants in total. It began in 2021-04-12 with a primary completion date of 2026-01-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Post-cardiac arrest mortality remains high and proper care after cardiopulmonary resuscitation is an important clinical challenge. This prospective observational cohort aims to (1) identify the factors that affect short-term and long-term survival in post-cardiac arrest survivors and (2) investigate the patients and their families' health-related quality of life and psychological well-being.

Eligibility Criteria

Inclusion Criteria: 1\. Patients with non-traumatic cardiac arrest, who have successfully sustained return of spontaneous circulation for more than five minutes after resuscitation efforts. Exclusion Criteria: 1. Under 20 years of age 2. Pregnant 3. Terminally ill cancer patients or cancer patients who are unwilling to receive treatment 4. When the ICU is over capacity and unable to provide intensive care. 5. The patient or family members refused to participate in this study.

Contact & Investigator

Central Contact

Min-Shan Tsai, MD, PhD

✉ mshanmshan@gmail.com

📞 886-2-23562831

Principal Investigator

Min-Shan Tsai, MD, PhD

PRINCIPAL INVESTIGATOR

National Taiwan University Hospital

Frequently Asked Questions

Who can join the NCT04859270 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, studying Post-Cardiac Arrest Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04859270 currently recruiting?

Yes, NCT04859270 is actively recruiting participants. Contact the research team at mshanmshan@gmail.com for enrollment information.

Where is the NCT04859270 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT04859270 clinical trial?

NCT04859270 is sponsored by National Taiwan University Hospital. The principal investigator is Min-Shan Tsai, MD, PhD at National Taiwan University Hospital. The trial plans to enroll 600 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology